Advertisement Pharmaceutical Business review - Page 1989 of 5284 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
August 5, 2026

Phylo and Chugai collaborate to deploy AI platform in drug discovery

Phylo has entered a collaboration with Japan-based company Chugai Pharmaceutical to implement Biomni Lab, an agentic AI platform designed for biomedical research, within the latter’s drug discovery operations.

Continue
The platform will be used across Chugai’s research, including human genetics, disease biology, and target evaluation. Credit: Gorodenkoff / Shutterstock.com.
August 5, 2026

AsymBio to secure $184m to support growth in biologics manufacturing

The additional capital comes as AsymBio expands its research and development capabilities, GMP manufacturing lines. Credit: Premreuthai / Shutterstock.com.
August 4, 2026

FDA grants breakthrough therapy designation to Lilly’s olomorasib

Olomorasib is an investigational inhibitor targeting the KRAS G12C protein, under study for various solid tumours. Credit: Sai Thaw Kyar / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Curium to acquire Lantheus in all-cash deal worth up to $8bn
  2. IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib
  3. Ratio Therapeutics secures $70m Series C funding for cancer radiotherapy
  4. miRecule and Rio Biofarma to develop RNA therapeutic delivery technologies
  5. Resilience and Lilly to increase US medicines production with $750m investment

PRESS RELEASES

Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography